Irvine, CA, United States of America

Nathan Chu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathan Chu - Innovator in Medical Technology

Introduction

Nathan Chu is a prominent inventor based in Irvine, CA, who has made significant contributions to the field of medical technology. His innovative work focuses on developing solutions that enhance patient care and improve medical procedures.

Latest Patents

Nathan Chu holds a patent for an intraluminal stent designed for treating benign prostatic hyperplasia. This stent is specifically configured to maintain the patency of the prostatic urethra, even in the presence of an enlarged prostate. The design includes a handle that remains outside the flow path of the stent when in an undeflected position. When the handle is pulled, it aligns with the central axis of the stent, facilitating its use. Additionally, a capture device with a tapered tip is included to navigate the working channel of a delivery device, allowing for efficient maneuvering of the stent. A loading adapter with a tapered port is also part of the design, which helps distribute compressive forces during the loading process.

Career Highlights

Nathan Chu is currently associated with Rivermark Medical, Inc., where he continues to innovate in the medical device sector. His work has been instrumental in advancing technologies that address common medical issues, particularly in urology.

Collaborations

Nathan has collaborated with notable professionals in his field, including Adam Kadlec and Anand Doraiswamy. These partnerships have contributed to the development of cutting-edge medical solutions.

Conclusion

Nathan Chu's contributions to medical technology, particularly through his patented intraluminal stent, highlight his commitment to improving patient outcomes. His work exemplifies the impact of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…